Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of IV Lignocaine Versus IV Nalbuphine for Attenuation of Pressor Response Diring Laryngoscopy and Intubation in Patients Planned for Thyroid Surgery

NCT05298761 is registered in ClinicalTrials.gov with Sheikh Zayed Medical College as lead sponsor.

NCT NCT05298761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05298761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of IV Lignocaine Versus IV Nalbuphine for Attenuation of Pressor Response Diring Laryngoscopy and Intubation in Patients Planned for Thyroid Surgery
Lead sponsor
Sheikh Zayed Medical College
Phase
Phase 1
Overall status
Unknown status
Start date
December 30, 2023
Completion date
June 1, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic stability